Jefferies Financial Group Inc. Biogen Inc. Transaction History

Jefferies Financial Group Inc.

$13.5 Billion
Q3 2024

A detailed history of Jefferies Financial Group Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 43,027 shares of BIIB stock, worth $6.73 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

43,027

Previous 3,308 1200.7%

Holding current value

$6.73 Million

Previous $766,000 988.77%

% of portfolio

0.06%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $7.51 Million - $9.41 Million	39,719 Added 1200.7%	43,027 $8.34 Million
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $109,739 - $136,350	-576 Reduced 14.83%	3,308 $766,000
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $9,540 - $12,046	-45 Reduced 1.15%	3,884 $837,000
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $1.24 Million - $1.49 Million	-5,561 Reduced 58.6%	3,929 $1.02 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $1.53 Million - $1.72 Million	6,021 Added 173.57%	9,490 $2.44 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $42,663 - $49,299	-155 Reduced 4.28%	3,469 $988,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $4.83 Million - $5.5 Million	-18,822 Reduced 83.85%	3,624 $1.01 Million
Q4 2022 Sep 21, 2023	BUY	$252.44 - $306.72 $4.54 Million - $5.51 Million	17,973 Added 518.1%	21,442 $5.94 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $5.67 Million - $6.88 Million	22,446 New	22,446 $6.22 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $902,159 - $994,436	-4,114 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $1.61 Million - $2.51 Million	-7,412 Reduced 64.31%	4,114 $972,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $179,075 - $226,818	643 Added 5.91%	11,526 $3.47 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $349,863 - $457,525	-1,192 Reduced 9.87%	10,883 $3.85 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $1.48 Million - $1.76 Million	5,744 Added 90.73%	12,075 $3.51 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $1.25 Million - $1.76 Million	4,794 Added 311.91%	6,331 $1.73 Million
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $472,842 - $529,619	1,537	1,537 $490,000

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Account

Jefferies Financial Group Inc. Biogen Inc. Transaction History